Clinical trial
A Double Blinded Randomized Controlled Study of Topical Anaesthetics Oxybuprocaine Versus Bupivacaine 0.5% in Intravitreal Injections
NCT05069350 is registered in ClinicalTrials.gov with Research Institute of Ophthalmology, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blinded Randomized Controlled Study of Topical Anaesthetics Oxybuprocaine Versus Bupivacaine 0.5% in Intravitreal Injections
- Lead sponsor
- Research Institute of Ophthalmology, Egypt
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- August 1, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, acute